Skandinaviska Enskilda Banken Ab (Publ) Arvinas, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Arvinas, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 9,806 shares of ARVN stock, worth $88,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,806
Previous 9,806
-0.0%
Holding current value
$88,744
Previous $241,000
22.41%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
225Shares Held
70.8MCall Options Held
1.52MPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA7.06MShares$63.9 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$60.9 Million6.03% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$56.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.1MShares$37.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$30.2 Million1.04% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $482M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...